Reported Earlier, Ascentage Pharma Group H1 EPS $(0.32) Beats $(0.44) Estimate, Sales $44.541M Beat $24.070M Estimate
Ascentage Pharma Group (NASDAQ:AAPG) reported quarterly losses of $(0.32) per share which beat the analyst consensus estimate of $(0.44) by 27.27 percent. This is a 33.33 percent decrease over losses of $(0.24) per